Hard to Treat Diseases Inc. (PINK SHEETS: HTDS) has appointed Fred Carlini as a strategic advisor. Mr. Carlini is the former Head of Worldwide Development for Roche Labs, a business unit of Hoffman LaRoche. Mr. Carlini is currently the President of THE S.M.A.R.T. Group, a team who consults for companies to assist in developing business plans for the healthcare market, negotiating major contracts, and aligning them with key strategic partners which compliment their business models.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
HTDS Medical has found the best way to increase shareholder value, separate and apart from the operating performance of operating subsidiaries, by spinning off and distributing shares of its wholly owned subsidiaries in the form of a special dividend to the Company’s shareholders.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
